Antibodies That Bind Human Protein Tyrosine Phosphatase Beta (HPTPBETA)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 60/790,506, filed Apr 7, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,926,367 | ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF In force · High confidence | Eyepoint, Inc. | In force | High confidence | ||
| US 11,814,425 | ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF In force · Medium confidence | Eyepoint, Inc. | In force | Medium confidence | ||
| US 8,524,235 | Method for Treating Coronary Artery Disease Using Antibody Binding Human Protein Tyrosine Phosphatase Beta(HPTPbeta) In force · High confidence | Eyepoint, Inc. | In force | High confidence | ||
| US 7,973,142 | Antibodies That Bind Human Protein Tyrosine Phosphatase Beta (HPTPBETA) In force · High confidence | Eyepoint, Inc. | In force | High confidence | ||
| Application 13/958,990 | ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES TEHREOF Abandoned Abandoned Mar 1, 2017 | Eyepoint Pharmaceuticals, Inc. | Abandoned | Abandoned Mar 1, 2017 | ||
| Application 15/894,442 | ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF Abandoned Abandoned Jun 3, 2020 | Eyepoint Pharmaceuticals, Inc. | Abandoned | Abandoned Jun 3, 2020 |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Eyepoint, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.